The role of splicing factors in deregulation of alternative splicing during oncogenesis and tumor progression

In past decades, cancer research has focused on genetic alterations that are detected in malignant tissues and contribute to the initiation and progression of cancer. These changes include mutations, copy number variations, and translocations. However, it is becoming increasingly clear that epigenet...

Full description

Saved in:
Bibliographic Details
Published inMolecular & cellular oncology Vol. 2; no. 1; p. e970955
Main Authors Shilo, Asaf, Siegfried, Zahava, Karni, Rotem
Format Journal Article
LanguageEnglish
Published United States Taylor & Francis 02.01.2015
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:In past decades, cancer research has focused on genetic alterations that are detected in malignant tissues and contribute to the initiation and progression of cancer. These changes include mutations, copy number variations, and translocations. However, it is becoming increasingly clear that epigenetic changes, including alternative splicing, play a major role in cancer development and progression. There are relatively few studies on the contribution of alternative splicing and the splicing factors that regulate this process to cancer development and progression. Recently, multiple studies have revealed altered splicing patterns in cancers and several splicing factors were found to contribute to tumor development. Studies using high-throughput genomic analysis have identified mutations in components of the core splicing machinery and in splicing factors in several cancers. In this review, we will highlight new findings on the role of alternative splicing and its regulators in cancer initiation and progression, in addition to novel approaches to correct oncogenic splicing.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:2372-3556
2372-3548
2372-3556
DOI:10.4161/23723548.2014.970955